OOIR: Observatory of International Research

Papers

(The H4-Index of Research in Social & Administrative Pharmacy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices	263
Developing a short screener for acquiescent respondents	186
Development of the Adolescent Opioid Safety and Learning (AOSL) scale using exploratory factor analysis	133
Simplifying medication regimens for residents of aged care facilities: Pharmacist and physician use of a structured five-step medication simplification tool	122
Role of clinical pharmacists in multidisciplinary collaborative management of blood glucose in COVID-19 patients with hyperglycemia	93
The impact of a provider motivational interviewing-based training on chronic pain management in a federally-qualified health center	78
Assessing the Impact and Lessons Learned from Surveillance and Prescribing Support for Antimicrobial Stewardship in Africa and Asia: A Mixed Methods Evaluation	69
Medicine Articles on English Wikipedia: Quantifying the Presence of Pharmaceutical Industry Edits and Describing their Content.	69
The adverse inpatient medication event and frailty (AIME-frail) risk prediction model	65
“It will not be easy to accept”: Parents conflicting attitudes towards pre-exposure prophylaxis for HIV prevention amongst adolescent girls and young women	61
Impact of pharmacist-led pharmaceutical care on health-related and pharmaceutical therapy-related quality of life in patients with heart failure: A randomized controlled trial	55
Practical naloxone communication tips for pharmacists: Lessons learned from the Linguistic Model of Patient Participation in Care	49
Root cause analysis of medication errors of the most frequently involved active substances in paediatric patients	45
Exploring stakeholders’ perspectives on antibiogram use, development, and implementation in residential aged care settings	42
Association of low-income subsidy, medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries	41
Incorporation of pharmacist pre-surgical calls to improve medication history completion rates	39
Impact of pharmacist interventions during transition of care in older adults to reduce the use of healthcare services: A scoping review	35
Pharmacist, nurse, and physician perspectives on the implementation of the pharmacist discharge care (pharm-dc) intervention: A qualitative study	34
Patient-reported outcome measures for medication-related quality of life: A scoping review	32
Development and evaluation of a model to identify publications on the clinical impact of pharmacist interventions	31
Complementary and alternative medicine use during the COVID-19 pandemic: Community pharmacists’ knowledge, attitudes, and practices	30
Pharmacy practice and social pharmacy forging ahead	29
Totally devoted to you: A qualitative study examining the experiences of sacrifice among pharmacists in rural and regional areas	29
Development, content validation and standardization of an adult patient prioritization tool for hospital clinical pharmacy services	28
Hidden factors in community pharmacy related to medication safety risks: Pushing patient safety to breaking point	28

Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review	27
Biopsychosocial analysis of antibiotic use for the prevention or management of COVID-19 infections: A scoping review	27